{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T10:19:55Z","timestamp":1705313995015},"reference-count":37,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,1,1]]},"abstract":"<jats:p>When interleukin-2 (IL-2) was added to immature, low-ploidy (greater than 80% 2N+4N) megakaryocytes generated in IL-3 and stem cell factor (SCF)\u2013containing liquid cultures of blood mononuclear cells highly enriched in hematopoietic progenitors, a 2- to 6-fold increase in the absolute number of polyploid (more than 8N) megakaryocytes was noted. This effect was found to be indirect and was mediated through natural killer (NK) cells that constitute the major lymphoid cell contaminating day 6 megakaryocyte cell populations. IL-2 had no effect on megakaryocytes generated from CD34+ cells stimulated with IL-3 and SCF. However, medium conditioned by IL-2\u2013stimulated, but not resting, NK cells (NKCM) contained a trypsin-sensitive factor capable of increasing 2- to 5-fold the number of polyploid megakaryocytes generated in vitro from IL-3 and SCF-stimulated CD34+ cells. The activity in NKCM was dose dependent and could not be neutralized by an excess of antibodies to IL-6, IL-11, leukemia inhibitory factor (LIF), gp130, stromal cell derived factor-1a (SDF-1a), and thrombopoietin (TPO). Addition of IL-11, but not TPO, to NKCM-containing cultures resulted in further augmentation of polyploidy, with the generation of 50% to 70% polyploid megakaryocytes with a modal ploidy of 16N. This factor is distinct from TPO because it induces endomitosis in IL-3\u2013generated megakaryocytes in vitro, whereas TPO does not, and its activity on megakaryocyte ploidy is not altered by optimal concentrations of TPO. In addition, no message for TPO is detectable in IL-2\u2013stimulated NK cells by reverse transcription\u2013polymerase chain reaction. These findings indicate that IL-2\u2013stimulated NK cells produce a novel peptide, distinct from TPO, IL-6, IL-11, LIF, other gp130-associated interleukins, and SDF1a, that can induce in vitro endomitosis in immature human megakaryocytes in the presence of IL-3 and SCF.<\/jats:p>","DOI":"10.1182\/blood.v99.1.130","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:40Z","timestamp":1027774000000},"page":"130-136","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Secretion of a unique peptide from interleukin-2\u2013stimulated natural killer cells that induces endomitosis in immature human megakaryocytes"],"prefix":"10.1182","volume":"99","author":[{"given":"Pantep","family":"Angchaisuksiri","sequence":"first","affiliation":[{"name":"From the Division of Hematology\/Oncology, Hunter Holmes McGuire Department of Veterans Affairs Medical Center, and the Medical College of Virginia, Virginia Commonwealth University, Richmond, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn R.","family":"Grigus","sequence":"additional","affiliation":[{"name":"From the Division of Hematology\/Oncology, Hunter Holmes McGuire Department of Veterans Affairs Medical Center, and the Medical College of Virginia, Virginia Commonwealth University, Richmond, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia L.","family":"Carlson","sequence":"additional","affiliation":[{"name":"From the Division of Hematology\/Oncology, Hunter Holmes McGuire Department of Veterans Affairs Medical Center, and the Medical College of Virginia, Virginia Commonwealth University, Richmond, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey W.","family":"Krystal","sequence":"additional","affiliation":[{"name":"From the Division of Hematology\/Oncology, Hunter Holmes McGuire Department of Veterans Affairs Medical Center, and the Medical College of Virginia, Virginia Commonwealth University, Richmond, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel N.","family":"Dessypris","sequence":"additional","affiliation":[{"name":"From the Division of Hematology\/Oncology, Hunter Holmes McGuire Department of Veterans Affairs Medical Center, and the Medical College of Virginia, Virginia Commonwealth University, Richmond, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021216542601500_B1","first-page":"194","article-title":"Evaluation of bone marrow megakaryocyte ploidy distributions in persons with normal and abnormal platelet counts.","volume":"111","author":"Mazur","year":"1988","journal-title":"J Laboratory Clin Med."},{"key":"2020021216542601500_B2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/blood.V74.2.594.594","article-title":"Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts.","volume":"74","author":"Tomer","year":"1989","journal-title":"Blood."},{"key":"2020021216542601500_B3","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1182\/blood.V85.7.1719.bloodjournal8571719","article-title":"Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.","volume":"85","author":"Broudy","year":"1995","journal-title":"Blood."},{"key":"2020021216542601500_B4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/369571a0","article-title":"cMpl ligand is a humoral regulator of megakaryocytopoiesis.","volume":"369","author":"Wendling","year":"1994","journal-title":"Nature."},{"key":"2020021216542601500_B5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2141.1996.4761013.x","article-title":"Effects of recombinant human thrombopoietin on megakaryocyte colony formation and megakaryocyte ploidy by human CD34+ cells in a serum-free system.","volume":"93","author":"Angchaisuksiri","year":"1996","journal-title":"Br J Haematol."},{"key":"2020021216542601500_B6","first-page":"546","article-title":"Replication and endoreplication in developing megakaryocytes in vitro.","volume":"22","author":"Angchaisuksiri","year":"1994","journal-title":"Exp Hematol."},{"key":"2020021216542601500_B7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI113080","article-title":"Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin.","volume":"80","author":"Sawada","year":"1987","journal-title":"J Clin Invest."},{"key":"2020021216542601500_B8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V65.5.1105.1105","article-title":"Depletion of stromal elements in human marrow grafts separated by soybean agglutinin.","volume":"65","author":"Ebell","year":"1985","journal-title":"Blood."},{"key":"2020021216542601500_B9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells [review].","volume":"47","author":"Trinchieri","year":"1989","journal-title":"Adv Immunol."},{"key":"2020021216542601500_B10","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood.V63.4.768.768","article-title":"Two-color flow cytometric measurement of DNA distributions of rat megakaryocytes in unfixed, unfractionated marrow cell suspensions.","volume":"63","author":"Jackson","year":"1984","journal-title":"Blood."},{"key":"2020021216542601500_B11","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1016\/S0021-9258(19)63382-X","article-title":"Isolation and in vitro translation of the messenger RNA coding for pancreatic amylase.","volume":"252","author":"MacDonald","year":"1977","journal-title":"J Biol Chem."},{"key":"2020021216542601500_B12","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V76.12.2421.2421","article-title":"Biology and clinical relevance of human natural killer cells.","volume":"76","author":"Robertson","year":"1990","journal-title":"Blood."},{"key":"2020021216542601500_B13","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood.V97.9.2587","article-title":"Stromal cell-derived factor 1 increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells.","volume":"97","author":"Guerriero","year":"2001","journal-title":"Blood."},{"key":"2020021216542601500_B14","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1182\/blood.V77.11.2326.2326","article-title":"In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes.","volume":"77","author":"Debili","year":"1991","journal-title":"Blood."},{"key":"2020021216542601500_B15","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V80.12.3022.3022","article-title":"Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation.","volume":"80","author":"Debili","year":"1992","journal-title":"Blood."},{"key":"2020021216542601500_B16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V86.2.419.bloodjournal862419","article-title":"Thrombopoietin: the primary regulator of platelet production.","volume":"86","author":"Kaushansky","year":"1995","journal-title":"Blood."},{"key":"2020021216542601500_B17","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1182\/blood.V91.11.4118","article-title":"Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells.","volume":"91","author":"Williams","year":"1998","journal-title":"Blood."},{"key":"2020021216542601500_B18","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood.V86.7.2516.2516","article-title":"The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.","volume":"86","author":"Debili","year":"1995","journal-title":"Blood."},{"key":"2020021216542601500_B19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2141.1998.00579.x","article-title":"Complementary and antagonistic effects of IL-3 in the early development of human megakaryocytes in culture.","volume":"100","author":"Dolzanskiy","year":"1998","journal-title":"Br J Haematol."},{"key":"2020021216542601500_B20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/1097-0142(19950215)75:4<1030::AID-CNCR2820750420>3.0.CO;2-5","article-title":"The hematologic toxicity of interleukin-2 inpatients with metastatic melanoma and renal cell carcinoma.","volume":"75","author":"MacFarlane","year":"1995","journal-title":"Cancer."},{"key":"2020021216542601500_B21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0002-9343(90)90343-C","article-title":"Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion.","volume":"89","author":"Paciucci","year":"1990","journal-title":"Am J Med."},{"key":"2020021216542601500_B22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/07357909509024926","article-title":"Increase of plasma transforming growth factor beta during immunotherapy with IL-2.","volume":"13","author":"Puolakkainen","year":"1995","journal-title":"Cancer Invest."},{"key":"2020021216542601500_B23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood.V69.6.1737.1737","article-title":"Type beta transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro.","volume":"69","author":"Ishibashi","year":"1987","journal-title":"Blood."},{"key":"2020021216542601500_B24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V79.3.619.619","article-title":"Transforming growth factor beta inhibits megakaryocyte growth and endomitosis.","volume":"79","author":"Kuter","year":"1992","journal-title":"Blood."},{"key":"2020021216542601500_B25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-2143(96)90115-8","article-title":"Interleukin 2 induces increased platelet-endothelium interactions: a potential mechanism of toxicity.","volume":"128","author":"Lentsch","year":"1996","journal-title":"J Lab Clin Med."},{"key":"2020021216542601500_B26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1126\/science.8073287","article-title":"Thrombocytopenia in c-mpl deficient mice.","volume":"265","author":"Gurney","year":"1994","journal-title":"Science."},{"key":"2020021216542601500_B27","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood.V91.8.2745.2745_2745_2752","article-title":"Cytokine production and function in c-mpl deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.","volume":"91","author":"Gainsford","year":"1998","journal-title":"Blood."},{"key":"2020021216542601500_B28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood.V95.2.528","article-title":"The residual megakaryocyte and platelet production in c-mpl deficient mice is not dependent on the actions of interleukin 6, interleukin 11, or leukemia inhibitory factor.","volume":"95","author":"Gainsford","year":"2000","journal-title":"Blood."},{"key":"2020021216542601500_B29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/10428199209054910","article-title":"Serum interleukin-6 levels in patients with thrombocytosis.","volume":"8","author":"Hollen","year":"1992","journal-title":"Leuk Lymphoma."},{"key":"2020021216542601500_B30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000041038","article-title":"Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis.","volume":"103","author":"Akan","year":"2000","journal-title":"Acta Haematol."},{"key":"2020021216542601500_B31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0022-2143(99)90154-3","article-title":"Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis.","volume":"134","author":"Hsu","year":"1999","journal-title":"J Lab Clin Med."},{"key":"2020021216542601500_B32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0002-9343(98)00090-4","article-title":"Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis.","volume":"104","author":"Wang","year":"1998","journal-title":"Am J Med."},{"key":"2020021216542601500_B33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2141.1997.3823196.x","article-title":"Thrombopoietin levels in patients with primary and reactive thrombocytosis.","volume":"99","author":"Cerutti","year":"1997","journal-title":"Br J Haematol."},{"key":"2020021216542601500_B34","first-page":"1017","article-title":"Differential effect of natural killer cells on modulating CFU-Meg and BFU-E proliferation in situ.","volume":"17","author":"Pantel","year":"1989","journal-title":"Exp Hematol."},{"key":"2020021216542601500_B35","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.4049\/jimmunol.139.9.2915","article-title":"Role of natural killer cells, in comparison with T lymphocytes and monocytes, in the regulation of normal human megakaryocytopoiesis in vitro.","volume":"139","author":"Gewirtz","year":"1987","journal-title":"J Immunol."},{"key":"2020021216542601500_B36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bmt.1700952","article-title":"Enhancement of megakaryocytopoiesis by Campath-1G\u2013treated natural killer cells.","volume":"20","author":"Nagler","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"2020021216542601500_B37","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1182\/blood.V82.8.2577.2577","article-title":"Activated natural killer cells and interleukin-2 promote granulocytic and megakaryocytic reconstitution after syngeneic bone marrow transplantation in mice.","volume":"82","author":"Siefer","year":"1993","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/1\/130\/1679711\/h80102000130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/1\/130\/1679711\/h80102000130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T20:10:38Z","timestamp":1682280638000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/1\/130\/107285\/Secretion-of-a-unique-peptide-from"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.1.130","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1,1]]}}}